Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

2(40%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

40%

Ph phase_3

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 3Large-scale testing

1(33.3%)

N/ANon-phased studies

2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(3)

Detailed Status

Completed3

Recruiting1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 31 (33.3%)

N/A2 (66.7%)

Trials by Status

recruiting120%

completed360%

active_not_recruiting120%

Recent Activity

2 active trials

Showing 5 of 5

active_not_recruitingphase_3

Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection

NCT03927027

completednot_applicable

Clinical Trials (5)

Showing 5 of 5 trials

NCT03927027Phase 3

Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection

Active Not Recruiting

NCT03363087Not Applicable

High Density Scar Guided Atrial Fibrillation Mapping

Completed

NCT04964765

The Basel CardioInsightTM - 3D Mapping Study

Recruiting

NCT02641431Not Applicable

Epicardial Ablation in Brugada Syndrome

Completed

NCT02303613

A Validation of Current Hospital Triage Performance System Versus RETTS

Completed

All 5 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 5